Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy
Status:
Terminated
Trial end date:
2020-07-10
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well rolapitant hydrochloride works in preventing
nausea/vomiting in patients with sarcoma receiving chemotherapy. Antiemetic drugs, such as
rolapitant hydrochloride, may help control or prevent nausea and vomiting in patients treated
with chemotherapy.